nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ORM1—Erlotinib—pancreatic cancer	0.159	0.266	CbGbCtD
Doxazosin—KCNH2—Sunitinib—pancreatic cancer	0.0926	0.155	CbGbCtD
Doxazosin—CYP2C19—Tamoxifen—pancreatic cancer	0.0512	0.0854	CbGbCtD
Doxazosin—ABCB1—Tamoxifen—pancreatic cancer	0.0413	0.0689	CbGbCtD
Doxazosin—CYP2D6—Tamoxifen—pancreatic cancer	0.0389	0.0649	CbGbCtD
Doxazosin—ABCB1—Gemcitabine—pancreatic cancer	0.0356	0.0594	CbGbCtD
Doxazosin—ABCB1—Erlotinib—pancreatic cancer	0.0351	0.0586	CbGbCtD
Doxazosin—CYP2D6—Erlotinib—pancreatic cancer	0.0331	0.0552	CbGbCtD
Doxazosin—ABCB1—Irinotecan—pancreatic cancer	0.0317	0.0529	CbGbCtD
Doxazosin—ABCB1—Docetaxel—pancreatic cancer	0.0232	0.0388	CbGbCtD
Doxazosin—ABCB1—Sunitinib—pancreatic cancer	0.0231	0.0386	CbGbCtD
Doxazosin—ABCB1—Doxorubicin—pancreatic cancer	0.0173	0.0289	CbGbCtD
Doxazosin—CYP2D6—Doxorubicin—pancreatic cancer	0.0163	0.0272	CbGbCtD
Doxazosin—Leukopenia—Docetaxel—pancreatic cancer	0.00022	0.000654	CcSEcCtD
Doxazosin—Pollakiuria—Epirubicin—pancreatic cancer	0.00022	0.000654	CcSEcCtD
Doxazosin—Body temperature increased—Fluorouracil—pancreatic cancer	0.00022	0.000653	CcSEcCtD
Doxazosin—Palpitations—Docetaxel—pancreatic cancer	0.000217	0.000646	CcSEcCtD
Doxazosin—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000217	0.000646	CcSEcCtD
Doxazosin—Weight increased—Epirubicin—pancreatic cancer	0.000217	0.000644	CcSEcCtD
Doxazosin—Loss of consciousness—Docetaxel—pancreatic cancer	0.000216	0.000642	CcSEcCtD
Doxazosin—Weight decreased—Epirubicin—pancreatic cancer	0.000215	0.00064	CcSEcCtD
Doxazosin—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000215	0.000638	CcSEcCtD
Doxazosin—Cough—Docetaxel—pancreatic cancer	0.000215	0.000638	CcSEcCtD
Doxazosin—Angina pectoris—Doxorubicin—pancreatic cancer	0.000215	0.000638	CcSEcCtD
Doxazosin—Hypersensitivity—Irinotecan—pancreatic cancer	0.000214	0.000636	CcSEcCtD
Doxazosin—Pneumonia—Epirubicin—pancreatic cancer	0.000214	0.000634	CcSEcCtD
Doxazosin—Convulsion—Docetaxel—pancreatic cancer	0.000213	0.000633	CcSEcCtD
Doxazosin—Hypertension—Docetaxel—pancreatic cancer	0.000212	0.000631	CcSEcCtD
Doxazosin—Drowsiness—Epirubicin—pancreatic cancer	0.000212	0.000631	CcSEcCtD
Doxazosin—Bronchitis—Doxorubicin—pancreatic cancer	0.000212	0.00063	CcSEcCtD
Doxazosin—Arthralgia—Docetaxel—pancreatic cancer	0.000209	0.000622	CcSEcCtD
Doxazosin—Myalgia—Docetaxel—pancreatic cancer	0.000209	0.000622	CcSEcCtD
Doxazosin—Chest pain—Docetaxel—pancreatic cancer	0.000209	0.000622	CcSEcCtD
Doxazosin—Nausea—Sunitinib—pancreatic cancer	0.000209	0.000622	CcSEcCtD
Doxazosin—Asthenia—Irinotecan—pancreatic cancer	0.000208	0.000619	CcSEcCtD
Doxazosin—Jaundice—Epirubicin—pancreatic cancer	0.000207	0.000615	CcSEcCtD
Doxazosin—Conjunctivitis—Epirubicin—pancreatic cancer	0.000206	0.000613	CcSEcCtD
Doxazosin—Urinary tract infection—Epirubicin—pancreatic cancer	0.000206	0.000613	CcSEcCtD
Doxazosin—Dysuria—Doxorubicin—pancreatic cancer	0.000206	0.000612	CcSEcCtD
Doxazosin—Neutropenia—Doxorubicin—pancreatic cancer	0.000206	0.000612	CcSEcCtD
Doxazosin—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000205	0.000609	CcSEcCtD
Doxazosin—Dry mouth—Docetaxel—pancreatic cancer	0.000205	0.000608	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000205	0.000608	CcSEcCtD
Doxazosin—Sweating—Epirubicin—pancreatic cancer	0.000204	0.000605	CcSEcCtD
Doxazosin—Pollakiuria—Doxorubicin—pancreatic cancer	0.000203	0.000605	CcSEcCtD
Doxazosin—Asthenia—Gemcitabine—pancreatic cancer	0.000203	0.000603	CcSEcCtD
Doxazosin—Haematuria—Epirubicin—pancreatic cancer	0.000202	0.000601	CcSEcCtD
Doxazosin—Confusional state—Docetaxel—pancreatic cancer	0.000202	0.000601	CcSEcCtD
Doxazosin—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000201	0.000597	CcSEcCtD
Doxazosin—Oedema—Docetaxel—pancreatic cancer	0.000201	0.000596	CcSEcCtD
Doxazosin—Weight increased—Doxorubicin—pancreatic cancer	0.0002	0.000596	CcSEcCtD
Doxazosin—Epistaxis—Epirubicin—pancreatic cancer	0.0002	0.000595	CcSEcCtD
Doxazosin—Pruritus—Gemcitabine—pancreatic cancer	0.0002	0.000595	CcSEcCtD
Doxazosin—Infection—Docetaxel—pancreatic cancer	0.000199	0.000593	CcSEcCtD
Doxazosin—Weight decreased—Doxorubicin—pancreatic cancer	0.000199	0.000592	CcSEcCtD
Doxazosin—Sinusitis—Epirubicin—pancreatic cancer	0.000199	0.000592	CcSEcCtD
Doxazosin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000199	0.00059	CcSEcCtD
Doxazosin—Diarrhoea—Irinotecan—pancreatic cancer	0.000199	0.00059	CcSEcCtD
Doxazosin—Pneumonia—Doxorubicin—pancreatic cancer	0.000198	0.000587	CcSEcCtD
Doxazosin—Shock—Docetaxel—pancreatic cancer	0.000197	0.000587	CcSEcCtD
Doxazosin—Pruritus—Fluorouracil—pancreatic cancer	0.000197	0.000585	CcSEcCtD
Doxazosin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000197	0.000584	CcSEcCtD
Doxazosin—Drowsiness—Doxorubicin—pancreatic cancer	0.000196	0.000584	CcSEcCtD
Doxazosin—Tachycardia—Docetaxel—pancreatic cancer	0.000196	0.000582	CcSEcCtD
Doxazosin—Skin disorder—Docetaxel—pancreatic cancer	0.000195	0.000579	CcSEcCtD
Doxazosin—Bradycardia—Epirubicin—pancreatic cancer	0.000194	0.000576	CcSEcCtD
Doxazosin—Diarrhoea—Gemcitabine—pancreatic cancer	0.000194	0.000575	CcSEcCtD
Doxazosin—Dizziness—Irinotecan—pancreatic cancer	0.000192	0.000571	CcSEcCtD
Doxazosin—Jaundice—Doxorubicin—pancreatic cancer	0.000191	0.000569	CcSEcCtD
Doxazosin—Anorexia—Docetaxel—pancreatic cancer	0.000191	0.000569	CcSEcCtD
Doxazosin—Rhinitis—Epirubicin—pancreatic cancer	0.000191	0.000568	CcSEcCtD
Doxazosin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000191	0.000567	CcSEcCtD
Doxazosin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000191	0.000567	CcSEcCtD
Doxazosin—Hepatitis—Epirubicin—pancreatic cancer	0.000191	0.000566	CcSEcCtD
Doxazosin—Diarrhoea—Fluorouracil—pancreatic cancer	0.00019	0.000565	CcSEcCtD
Doxazosin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00019	0.000563	CcSEcCtD
Doxazosin—Pharyngitis—Epirubicin—pancreatic cancer	0.000189	0.000562	CcSEcCtD
Doxazosin—Sweating—Doxorubicin—pancreatic cancer	0.000188	0.00056	CcSEcCtD
Doxazosin—Hypotension—Docetaxel—pancreatic cancer	0.000188	0.000557	CcSEcCtD
Doxazosin—Haematuria—Doxorubicin—pancreatic cancer	0.000187	0.000556	CcSEcCtD
Doxazosin—Epistaxis—Doxorubicin—pancreatic cancer	0.000185	0.00055	CcSEcCtD
Doxazosin—Vomiting—Irinotecan—pancreatic cancer	0.000185	0.000549	CcSEcCtD
Doxazosin—Sinusitis—Doxorubicin—pancreatic cancer	0.000184	0.000548	CcSEcCtD
Doxazosin—Dizziness—Fluorouracil—pancreatic cancer	0.000184	0.000546	CcSEcCtD
Doxazosin—Visual impairment—Epirubicin—pancreatic cancer	0.000184	0.000546	CcSEcCtD
Doxazosin—Rash—Irinotecan—pancreatic cancer	0.000183	0.000544	CcSEcCtD
Doxazosin—Dermatitis—Irinotecan—pancreatic cancer	0.000183	0.000544	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000183	0.000543	CcSEcCtD
Doxazosin—Headache—Irinotecan—pancreatic cancer	0.000182	0.000541	CcSEcCtD
Doxazosin—Insomnia—Docetaxel—pancreatic cancer	0.000182	0.000539	CcSEcCtD
Doxazosin—Paraesthesia—Docetaxel—pancreatic cancer	0.00018	0.000536	CcSEcCtD
Doxazosin—Vomiting—Gemcitabine—pancreatic cancer	0.00018	0.000534	CcSEcCtD
Doxazosin—Bradycardia—Doxorubicin—pancreatic cancer	0.000179	0.000533	CcSEcCtD
Doxazosin—Dyspnoea—Docetaxel—pancreatic cancer	0.000179	0.000532	CcSEcCtD
Doxazosin—Somnolence—Docetaxel—pancreatic cancer	0.000178	0.00053	CcSEcCtD
Doxazosin—Rash—Gemcitabine—pancreatic cancer	0.000178	0.00053	CcSEcCtD
Doxazosin—Dermatitis—Gemcitabine—pancreatic cancer	0.000178	0.000529	CcSEcCtD
Doxazosin—Eye disorder—Epirubicin—pancreatic cancer	0.000178	0.000529	CcSEcCtD
Doxazosin—Tinnitus—Epirubicin—pancreatic cancer	0.000178	0.000528	CcSEcCtD
Doxazosin—Headache—Gemcitabine—pancreatic cancer	0.000177	0.000527	CcSEcCtD
Doxazosin—Flushing—Epirubicin—pancreatic cancer	0.000177	0.000526	CcSEcCtD
Doxazosin—Vomiting—Fluorouracil—pancreatic cancer	0.000177	0.000525	CcSEcCtD
Doxazosin—Rhinitis—Doxorubicin—pancreatic cancer	0.000177	0.000525	CcSEcCtD
Doxazosin—Dyspepsia—Docetaxel—pancreatic cancer	0.000177	0.000525	CcSEcCtD
Doxazosin—Hepatitis—Doxorubicin—pancreatic cancer	0.000176	0.000524	CcSEcCtD
Doxazosin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000175	0.000521	CcSEcCtD
Doxazosin—Rash—Fluorouracil—pancreatic cancer	0.000175	0.000521	CcSEcCtD
Doxazosin—Dermatitis—Fluorouracil—pancreatic cancer	0.000175	0.000521	CcSEcCtD
Doxazosin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000175	0.00052	CcSEcCtD
Doxazosin—Decreased appetite—Docetaxel—pancreatic cancer	0.000174	0.000518	CcSEcCtD
Doxazosin—Headache—Fluorouracil—pancreatic cancer	0.000174	0.000518	CcSEcCtD
Doxazosin—Fatigue—Docetaxel—pancreatic cancer	0.000173	0.000514	CcSEcCtD
Doxazosin—Nausea—Irinotecan—pancreatic cancer	0.000172	0.000512	CcSEcCtD
Doxazosin—Pain—Docetaxel—pancreatic cancer	0.000172	0.00051	CcSEcCtD
Doxazosin—Constipation—Docetaxel—pancreatic cancer	0.000172	0.00051	CcSEcCtD
Doxazosin—Chills—Epirubicin—pancreatic cancer	0.000171	0.000508	CcSEcCtD
Doxazosin—Arrhythmia—Epirubicin—pancreatic cancer	0.00017	0.000506	CcSEcCtD
Doxazosin—Visual impairment—Doxorubicin—pancreatic cancer	0.00017	0.000505	CcSEcCtD
Doxazosin—Alopecia—Epirubicin—pancreatic cancer	0.000168	0.0005	CcSEcCtD
Doxazosin—Nausea—Gemcitabine—pancreatic cancer	0.000168	0.000499	CcSEcCtD
Doxazosin—Mental disorder—Epirubicin—pancreatic cancer	0.000167	0.000496	CcSEcCtD
Doxazosin—Malnutrition—Epirubicin—pancreatic cancer	0.000166	0.000493	CcSEcCtD
Doxazosin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000165	0.000491	CcSEcCtD
Doxazosin—Nausea—Fluorouracil—pancreatic cancer	0.000165	0.000491	CcSEcCtD
Doxazosin—Eye disorder—Doxorubicin—pancreatic cancer	0.000165	0.00049	CcSEcCtD
Doxazosin—Tinnitus—Doxorubicin—pancreatic cancer	0.000164	0.000488	CcSEcCtD
Doxazosin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000164	0.000488	CcSEcCtD
Doxazosin—Flushing—Doxorubicin—pancreatic cancer	0.000164	0.000486	CcSEcCtD
Doxazosin—Flatulence—Epirubicin—pancreatic cancer	0.000163	0.000486	CcSEcCtD
Doxazosin—Tension—Epirubicin—pancreatic cancer	0.000163	0.000484	CcSEcCtD
Doxazosin—Dysgeusia—Epirubicin—pancreatic cancer	0.000162	0.000483	CcSEcCtD
Doxazosin—Nervousness—Epirubicin—pancreatic cancer	0.000161	0.000479	CcSEcCtD
Doxazosin—Back pain—Epirubicin—pancreatic cancer	0.00016	0.000477	CcSEcCtD
Doxazosin—Muscle spasms—Epirubicin—pancreatic cancer	0.000159	0.000474	CcSEcCtD
Doxazosin—Abdominal pain—Docetaxel—pancreatic cancer	0.000159	0.000471	CcSEcCtD
Doxazosin—Body temperature increased—Docetaxel—pancreatic cancer	0.000159	0.000471	CcSEcCtD
Doxazosin—Chills—Doxorubicin—pancreatic cancer	0.000158	0.00047	CcSEcCtD
Doxazosin—Arrhythmia—Doxorubicin—pancreatic cancer	0.000158	0.000468	CcSEcCtD
Doxazosin—Vision blurred—Epirubicin—pancreatic cancer	0.000156	0.000465	CcSEcCtD
Doxazosin—Alopecia—Doxorubicin—pancreatic cancer	0.000156	0.000463	CcSEcCtD
Doxazosin—Mental disorder—Doxorubicin—pancreatic cancer	0.000154	0.000459	CcSEcCtD
Doxazosin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000154	0.000457	CcSEcCtD
Doxazosin—Malnutrition—Doxorubicin—pancreatic cancer	0.000153	0.000456	CcSEcCtD
Doxazosin—Agitation—Epirubicin—pancreatic cancer	0.000152	0.000453	CcSEcCtD
Doxazosin—Flatulence—Doxorubicin—pancreatic cancer	0.000151	0.000449	CcSEcCtD
Doxazosin—Tension—Doxorubicin—pancreatic cancer	0.000151	0.000448	CcSEcCtD
Doxazosin—Dysgeusia—Doxorubicin—pancreatic cancer	0.00015	0.000447	CcSEcCtD
Doxazosin—Malaise—Epirubicin—pancreatic cancer	0.00015	0.000445	CcSEcCtD
Doxazosin—Nervousness—Doxorubicin—pancreatic cancer	0.000149	0.000443	CcSEcCtD
Doxazosin—Vertigo—Epirubicin—pancreatic cancer	0.000149	0.000443	CcSEcCtD
Doxazosin—Syncope—Epirubicin—pancreatic cancer	0.000149	0.000442	CcSEcCtD
Doxazosin—Leukopenia—Epirubicin—pancreatic cancer	0.000148	0.000441	CcSEcCtD
Doxazosin—Back pain—Doxorubicin—pancreatic cancer	0.000148	0.000441	CcSEcCtD
Doxazosin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000148	0.000439	CcSEcCtD
Doxazosin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000148	0.000438	CcSEcCtD
Doxazosin—Palpitations—Epirubicin—pancreatic cancer	0.000147	0.000436	CcSEcCtD
Doxazosin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000146	0.000433	CcSEcCtD
Doxazosin—Cough—Epirubicin—pancreatic cancer	0.000145	0.00043	CcSEcCtD
Doxazosin—Vision blurred—Doxorubicin—pancreatic cancer	0.000145	0.00043	CcSEcCtD
Doxazosin—Asthenia—Docetaxel—pancreatic cancer	0.000144	0.000428	CcSEcCtD
Doxazosin—Convulsion—Epirubicin—pancreatic cancer	0.000144	0.000427	CcSEcCtD
Doxazosin—Hypertension—Epirubicin—pancreatic cancer	0.000143	0.000426	CcSEcCtD
Doxazosin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000142	0.000423	CcSEcCtD
Doxazosin—Pruritus—Docetaxel—pancreatic cancer	0.000142	0.000422	CcSEcCtD
Doxazosin—Arthralgia—Epirubicin—pancreatic cancer	0.000141	0.00042	CcSEcCtD
Doxazosin—Chest pain—Epirubicin—pancreatic cancer	0.000141	0.00042	CcSEcCtD
Doxazosin—Myalgia—Epirubicin—pancreatic cancer	0.000141	0.00042	CcSEcCtD
Doxazosin—Agitation—Doxorubicin—pancreatic cancer	0.000141	0.000419	CcSEcCtD
Doxazosin—Anxiety—Epirubicin—pancreatic cancer	0.000141	0.000418	CcSEcCtD
Doxazosin—Discomfort—Epirubicin—pancreatic cancer	0.00014	0.000415	CcSEcCtD
Doxazosin—Malaise—Doxorubicin—pancreatic cancer	0.000138	0.000411	CcSEcCtD
Doxazosin—Dry mouth—Epirubicin—pancreatic cancer	0.000138	0.00041	CcSEcCtD
Doxazosin—Vertigo—Doxorubicin—pancreatic cancer	0.000138	0.00041	CcSEcCtD
Doxazosin—Syncope—Doxorubicin—pancreatic cancer	0.000138	0.000409	CcSEcCtD
Doxazosin—Leukopenia—Doxorubicin—pancreatic cancer	0.000137	0.000408	CcSEcCtD
Doxazosin—Diarrhoea—Docetaxel—pancreatic cancer	0.000137	0.000408	CcSEcCtD
Doxazosin—Confusional state—Epirubicin—pancreatic cancer	0.000137	0.000406	CcSEcCtD
Doxazosin—Palpitations—Doxorubicin—pancreatic cancer	0.000136	0.000403	CcSEcCtD
Doxazosin—Oedema—Epirubicin—pancreatic cancer	0.000135	0.000402	CcSEcCtD
Doxazosin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000135	0.000401	CcSEcCtD
Doxazosin—Infection—Epirubicin—pancreatic cancer	0.000134	0.0004	CcSEcCtD
Doxazosin—Cough—Doxorubicin—pancreatic cancer	0.000134	0.000398	CcSEcCtD
Doxazosin—Shock—Epirubicin—pancreatic cancer	0.000133	0.000396	CcSEcCtD
Doxazosin—Convulsion—Doxorubicin—pancreatic cancer	0.000133	0.000395	CcSEcCtD
Doxazosin—Dizziness—Docetaxel—pancreatic cancer	0.000133	0.000394	CcSEcCtD
Doxazosin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000133	0.000394	CcSEcCtD
Doxazosin—Hypertension—Doxorubicin—pancreatic cancer	0.000133	0.000394	CcSEcCtD
Doxazosin—Tachycardia—Epirubicin—pancreatic cancer	0.000132	0.000393	CcSEcCtD
Doxazosin—Skin disorder—Epirubicin—pancreatic cancer	0.000132	0.000391	CcSEcCtD
Doxazosin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000131	0.000389	CcSEcCtD
Doxazosin—Arthralgia—Doxorubicin—pancreatic cancer	0.000131	0.000388	CcSEcCtD
Doxazosin—Chest pain—Doxorubicin—pancreatic cancer	0.000131	0.000388	CcSEcCtD
Doxazosin—Myalgia—Doxorubicin—pancreatic cancer	0.000131	0.000388	CcSEcCtD
Doxazosin—Anxiety—Doxorubicin—pancreatic cancer	0.00013	0.000387	CcSEcCtD
Doxazosin—Discomfort—Doxorubicin—pancreatic cancer	0.000129	0.000384	CcSEcCtD
Doxazosin—Anorexia—Epirubicin—pancreatic cancer	0.000129	0.000383	CcSEcCtD
Doxazosin—Dry mouth—Doxorubicin—pancreatic cancer	0.000128	0.00038	CcSEcCtD
Doxazosin—Vomiting—Docetaxel—pancreatic cancer	0.000128	0.000379	CcSEcCtD
Doxazosin—Rash—Docetaxel—pancreatic cancer	0.000127	0.000376	CcSEcCtD
Doxazosin—Hypotension—Epirubicin—pancreatic cancer	0.000127	0.000376	CcSEcCtD
Doxazosin—Dermatitis—Docetaxel—pancreatic cancer	0.000126	0.000376	CcSEcCtD
Doxazosin—Confusional state—Doxorubicin—pancreatic cancer	0.000126	0.000375	CcSEcCtD
Doxazosin—Headache—Docetaxel—pancreatic cancer	0.000126	0.000374	CcSEcCtD
Doxazosin—Oedema—Doxorubicin—pancreatic cancer	0.000125	0.000372	CcSEcCtD
Doxazosin—Infection—Doxorubicin—pancreatic cancer	0.000124	0.00037	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000123	0.000367	CcSEcCtD
Doxazosin—Shock—Doxorubicin—pancreatic cancer	0.000123	0.000366	CcSEcCtD
Doxazosin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000123	0.000364	CcSEcCtD
Doxazosin—Insomnia—Epirubicin—pancreatic cancer	0.000122	0.000364	CcSEcCtD
Doxazosin—Tachycardia—Doxorubicin—pancreatic cancer	0.000122	0.000363	CcSEcCtD
Doxazosin—Skin disorder—Doxorubicin—pancreatic cancer	0.000122	0.000362	CcSEcCtD
Doxazosin—Paraesthesia—Epirubicin—pancreatic cancer	0.000122	0.000361	CcSEcCtD
Doxazosin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000121	0.00036	CcSEcCtD
Doxazosin—Dyspnoea—Epirubicin—pancreatic cancer	0.000121	0.000359	CcSEcCtD
Doxazosin—Somnolence—Epirubicin—pancreatic cancer	0.00012	0.000358	CcSEcCtD
Doxazosin—Anorexia—Doxorubicin—pancreatic cancer	0.000119	0.000355	CcSEcCtD
Doxazosin—Nausea—Docetaxel—pancreatic cancer	0.000119	0.000354	CcSEcCtD
Doxazosin—Dyspepsia—Epirubicin—pancreatic cancer	0.000119	0.000354	CcSEcCtD
Doxazosin—Decreased appetite—Epirubicin—pancreatic cancer	0.000118	0.00035	CcSEcCtD
Doxazosin—Hypotension—Doxorubicin—pancreatic cancer	0.000117	0.000348	CcSEcCtD
Doxazosin—Fatigue—Epirubicin—pancreatic cancer	0.000117	0.000347	CcSEcCtD
Doxazosin—Constipation—Epirubicin—pancreatic cancer	0.000116	0.000344	CcSEcCtD
Doxazosin—Pain—Epirubicin—pancreatic cancer	0.000116	0.000344	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000114	0.000339	CcSEcCtD
Doxazosin—Insomnia—Doxorubicin—pancreatic cancer	0.000113	0.000337	CcSEcCtD
Doxazosin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000112	0.000334	CcSEcCtD
Doxazosin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000112	0.000332	CcSEcCtD
Doxazosin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000112	0.000332	CcSEcCtD
Doxazosin—Somnolence—Doxorubicin—pancreatic cancer	0.000111	0.000331	CcSEcCtD
Doxazosin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000111	0.000329	CcSEcCtD
Doxazosin—Dyspepsia—Doxorubicin—pancreatic cancer	0.00011	0.000328	CcSEcCtD
Doxazosin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000109	0.000324	CcSEcCtD
Doxazosin—Fatigue—Doxorubicin—pancreatic cancer	0.000108	0.000321	CcSEcCtD
Doxazosin—Urticaria—Epirubicin—pancreatic cancer	0.000108	0.00032	CcSEcCtD
Doxazosin—Constipation—Doxorubicin—pancreatic cancer	0.000107	0.000318	CcSEcCtD
Doxazosin—Pain—Doxorubicin—pancreatic cancer	0.000107	0.000318	CcSEcCtD
Doxazosin—Body temperature increased—Epirubicin—pancreatic cancer	0.000107	0.000318	CcSEcCtD
Doxazosin—Abdominal pain—Epirubicin—pancreatic cancer	0.000107	0.000318	CcSEcCtD
Doxazosin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000103	0.000307	CcSEcCtD
Doxazosin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000102	0.000304	CcSEcCtD
Doxazosin—Hypersensitivity—Epirubicin—pancreatic cancer	9.97e-05	0.000296	CcSEcCtD
Doxazosin—Urticaria—Doxorubicin—pancreatic cancer	9.95e-05	0.000296	CcSEcCtD
Doxazosin—Abdominal pain—Doxorubicin—pancreatic cancer	9.9e-05	0.000294	CcSEcCtD
Doxazosin—Body temperature increased—Doxorubicin—pancreatic cancer	9.9e-05	0.000294	CcSEcCtD
Doxazosin—Asthenia—Epirubicin—pancreatic cancer	9.71e-05	0.000289	CcSEcCtD
Doxazosin—Pruritus—Epirubicin—pancreatic cancer	9.58e-05	0.000285	CcSEcCtD
Doxazosin—Diarrhoea—Epirubicin—pancreatic cancer	9.26e-05	0.000275	CcSEcCtD
Doxazosin—Hypersensitivity—Doxorubicin—pancreatic cancer	9.23e-05	0.000274	CcSEcCtD
Doxazosin—Asthenia—Doxorubicin—pancreatic cancer	8.99e-05	0.000267	CcSEcCtD
Doxazosin—Dizziness—Epirubicin—pancreatic cancer	8.95e-05	0.000266	CcSEcCtD
Doxazosin—Pruritus—Doxorubicin—pancreatic cancer	8.86e-05	0.000263	CcSEcCtD
Doxazosin—Vomiting—Epirubicin—pancreatic cancer	8.61e-05	0.000256	CcSEcCtD
Doxazosin—Diarrhoea—Doxorubicin—pancreatic cancer	8.57e-05	0.000255	CcSEcCtD
Doxazosin—Rash—Epirubicin—pancreatic cancer	8.54e-05	0.000254	CcSEcCtD
Doxazosin—Dermatitis—Epirubicin—pancreatic cancer	8.53e-05	0.000253	CcSEcCtD
Doxazosin—Headache—Epirubicin—pancreatic cancer	8.48e-05	0.000252	CcSEcCtD
Doxazosin—Dizziness—Doxorubicin—pancreatic cancer	8.28e-05	0.000246	CcSEcCtD
Doxazosin—Nausea—Epirubicin—pancreatic cancer	8.04e-05	0.000239	CcSEcCtD
Doxazosin—Vomiting—Doxorubicin—pancreatic cancer	7.96e-05	0.000237	CcSEcCtD
Doxazosin—Rash—Doxorubicin—pancreatic cancer	7.9e-05	0.000235	CcSEcCtD
Doxazosin—Dermatitis—Doxorubicin—pancreatic cancer	7.89e-05	0.000234	CcSEcCtD
Doxazosin—Headache—Doxorubicin—pancreatic cancer	7.85e-05	0.000233	CcSEcCtD
Doxazosin—Nausea—Doxorubicin—pancreatic cancer	7.44e-05	0.000221	CcSEcCtD
Doxazosin—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.79e-05	0.000277	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JAG1—pancreatic cancer	1.77e-05	0.000274	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOTCH3—pancreatic cancer	1.76e-05	0.000273	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.76e-05	0.000272	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	1.75e-05	0.00027	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CXCL8—pancreatic cancer	1.74e-05	0.00027	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	1.74e-05	0.000269	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—SRC—pancreatic cancer	1.74e-05	0.000269	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CD—pancreatic cancer	1.73e-05	0.000268	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.69e-05	0.000262	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VEGFA—pancreatic cancer	1.69e-05	0.000262	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.69e-05	0.000262	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CNR1—pancreatic cancer	1.67e-05	0.000259	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—NRAS—pancreatic cancer	1.67e-05	0.000259	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TERT—pancreatic cancer	1.66e-05	0.000257	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.66e-05	0.000257	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	1.66e-05	0.000257	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	1.63e-05	0.000253	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.63e-05	0.000252	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	1.62e-05	0.000251	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—GCG—pancreatic cancer	1.61e-05	0.00025	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SMAD4—pancreatic cancer	1.61e-05	0.000249	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.6e-05	0.000248	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCL8—pancreatic cancer	1.59e-05	0.000247	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HIF1A—pancreatic cancer	1.59e-05	0.000246	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TSC2—pancreatic cancer	1.58e-05	0.000245	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HES1—pancreatic cancer	1.57e-05	0.000244	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.57e-05	0.000243	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—TYMS—pancreatic cancer	1.56e-05	0.000242	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TGFB1—pancreatic cancer	1.55e-05	0.00024	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOE—pancreatic cancer	1.55e-05	0.00024	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGTR1—pancreatic cancer	1.54e-05	0.000238	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.53e-05	0.000238	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KDR—pancreatic cancer	1.52e-05	0.000235	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STK11—pancreatic cancer	1.52e-05	0.000235	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CB—pancreatic cancer	1.51e-05	0.000233	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.47e-05	0.000228	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCL8—pancreatic cancer	1.45e-05	0.000224	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NFKBIA—pancreatic cancer	1.44e-05	0.000224	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—KRAS—pancreatic cancer	1.44e-05	0.000223	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	1.43e-05	0.000222	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOTCH1—pancreatic cancer	1.43e-05	0.000222	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CD44—pancreatic cancer	1.43e-05	0.000221	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.43e-05	0.000221	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.42e-05	0.000219	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CG—pancreatic cancer	1.4e-05	0.000217	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—NRAS—pancreatic cancer	1.4e-05	0.000217	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	1.4e-05	0.000216	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.4e-05	0.000216	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CD44—pancreatic cancer	1.39e-05	0.000216	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.38e-05	0.000214	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGF—pancreatic cancer	1.38e-05	0.000214	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TERT—pancreatic cancer	1.38e-05	0.000213	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.37e-05	0.000212	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GCG—pancreatic cancer	1.37e-05	0.000212	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.34e-05	0.000207	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GCG—pancreatic cancer	1.33e-05	0.000207	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SMAD4—pancreatic cancer	1.33e-05	0.000206	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PIK3CA—pancreatic cancer	1.32e-05	0.000204	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HIF1A—pancreatic cancer	1.32e-05	0.000204	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.32e-05	0.000204	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TSC2—pancreatic cancer	1.31e-05	0.000204	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CD44—pancreatic cancer	1.31e-05	0.000203	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HES1—pancreatic cancer	1.3e-05	0.000201	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOE—pancreatic cancer	1.29e-05	0.000199	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—STK11—pancreatic cancer	1.29e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	1.29e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—pancreatic cancer	1.28e-05	0.000198	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EGFR—pancreatic cancer	1.27e-05	0.000197	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—pancreatic cancer	1.27e-05	0.000197	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KDR—pancreatic cancer	1.26e-05	0.000195	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GCG—pancreatic cancer	1.26e-05	0.000195	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—STK11—pancreatic cancer	1.25e-05	0.000194	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.24e-05	0.000192	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CD—pancreatic cancer	1.23e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	1.22e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—HRAS—pancreatic cancer	1.22e-05	0.000189	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.22e-05	0.000189	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.21e-05	0.000187	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—KRAS—pancreatic cancer	1.2e-05	0.000186	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NFKBIA—pancreatic cancer	1.2e-05	0.000186	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.19e-05	0.000185	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOTCH1—pancreatic cancer	1.19e-05	0.000184	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—STK11—pancreatic cancer	1.18e-05	0.000183	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	1.17e-05	0.000181	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	1.17e-05	0.000181	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CG—pancreatic cancer	1.16e-05	0.00018	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—NRAS—pancreatic cancer	1.16e-05	0.00018	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGF—pancreatic cancer	1.15e-05	0.000178	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	1.15e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	1.14e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	1.14e-05	0.000176	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	1.12e-05	0.000173	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.11e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PIK3CA—pancreatic cancer	1.11e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—pancreatic cancer	1.11e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	1.09e-05	0.000168	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	1.08e-05	0.000168	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TYMS—pancreatic cancer	1.08e-05	0.000167	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—pancreatic cancer	1.08e-05	0.000167	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CB—pancreatic cancer	1.07e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	1.06e-05	0.000165	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	1.06e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	1.06e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	1.05e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	1.04e-05	0.000161	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	1.03e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	1.03e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—pancreatic cancer	1.03e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—HRAS—pancreatic cancer	1.02e-05	0.000158	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	1.02e-05	0.000158	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	1.02e-05	0.000158	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.02e-05	0.000158	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.01e-05	0.000157	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	1.01e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	9.99e-06	0.000155	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	9.95e-06	0.000154	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	9.89e-06	0.000153	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	9.86e-06	0.000153	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	9.8e-06	0.000152	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	9.59e-06	0.000149	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	9.58e-06	0.000148	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	9.58e-06	0.000148	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	9.5e-06	0.000147	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	9.47e-06	0.000147	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	9.39e-06	0.000146	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	9.32e-06	0.000144	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	9.26e-06	0.000143	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	9.18e-06	0.000142	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	9.06e-06	0.00014	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	9.03e-06	0.00014	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—pancreatic cancer	8.99e-06	0.000139	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.98e-06	0.000139	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	8.9e-06	0.000138	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	8.87e-06	0.000137	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	8.78e-06	0.000136	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—pancreatic cancer	8.78e-06	0.000136	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	8.73e-06	0.000135	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—pancreatic cancer	8.7e-06	0.000135	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	8.59e-06	0.000133	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	8.55e-06	0.000132	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.51e-06	0.000132	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	8.49e-06	0.000132	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	8.42e-06	0.00013	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	8.36e-06	0.00013	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.34e-06	0.000129	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	8.28e-06	0.000128	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—pancreatic cancer	8.27e-06	0.000128	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	8.26e-06	0.000128	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	8.26e-06	0.000128	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	8.25e-06	0.000128	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	8.18e-06	0.000127	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	8.15e-06	0.000126	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	8.12e-06	0.000126	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	7.96e-06	0.000123	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CG—pancreatic cancer	7.92e-06	0.000123	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	7.9e-06	0.000122	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	7.89e-06	0.000122	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—pancreatic cancer	7.83e-06	0.000121	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	7.73e-06	0.00012	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	7.7e-06	0.000119	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	7.69e-06	0.000119	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	7.68e-06	0.000119	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—pancreatic cancer	7.65e-06	0.000118	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	7.59e-06	0.000118	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTEN—pancreatic cancer	7.59e-06	0.000118	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	7.58e-06	0.000117	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	7.54e-06	0.000117	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	7.53e-06	0.000117	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	7.5e-06	0.000116	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	7.47e-06	0.000116	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	7.34e-06	0.000114	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	7.33e-06	0.000114	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	7.27e-06	0.000113	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—pancreatic cancer	7.21e-06	0.000112	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	7.14e-06	0.000111	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	7.13e-06	0.00011	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	7.11e-06	0.00011	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	7.07e-06	0.00011	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	7.05e-06	0.000109	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	7.01e-06	0.000109	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	7e-06	0.000108	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CD—pancreatic cancer	6.97e-06	0.000108	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	6.94e-06	0.000108	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	6.87e-06	0.000106	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	6.87e-06	0.000106	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	6.86e-06	0.000106	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	6.83e-06	0.000106	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	6.82e-06	0.000106	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	6.75e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	6.66e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	6.57e-06	0.000102	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	6.56e-06	0.000102	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	6.53e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.51e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	6.39e-06	9.89e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	6.38e-06	9.88e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	6.37e-06	9.87e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	6.34e-06	9.83e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	6.33e-06	9.81e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	6.32e-06	9.79e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	6.25e-06	9.68e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	6.22e-06	9.63e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	6.19e-06	9.59e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	6.17e-06	9.55e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—pancreatic cancer	6.16e-06	9.55e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	6.11e-06	9.46e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	6.09e-06	9.43e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CB—pancreatic cancer	6.07e-06	9.4e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	6.04e-06	9.36e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—pancreatic cancer	6.02e-06	9.32e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	5.9e-06	9.14e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	5.88e-06	9.11e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	5.73e-06	8.87e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	5.72e-06	8.86e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	5.67e-06	8.79e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	5.67e-06	8.79e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—pancreatic cancer	5.67e-06	8.78e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	5.66e-06	8.77e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	5.66e-06	8.77e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	5.55e-06	8.6e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	5.42e-06	8.4e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTEN—pancreatic cancer	5.37e-06	8.33e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	5.35e-06	8.29e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	5.34e-06	8.27e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	5.27e-06	8.17e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	5.26e-06	8.15e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTEN—pancreatic cancer	5.25e-06	8.13e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	5.25e-06	8.13e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	5.24e-06	8.12e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	5.16e-06	7.99e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	5.02e-06	7.77e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.94e-06	7.66e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	4.87e-06	7.54e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.82e-06	7.46e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	4.66e-06	7.22e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.48e-06	6.93e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	4.46e-06	6.9e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	4.43e-06	6.86e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—pancreatic cancer	4.37e-06	6.77e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	4.33e-06	6.71e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	4.14e-06	6.41e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	3.93e-06	6.09e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	3.79e-06	5.87e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.7e-06	5.73e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	3.66e-06	5.66e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.49e-06	5.4e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—pancreatic cancer	3.1e-06	4.8e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—pancreatic cancer	3.02e-06	4.68e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.85e-06	4.41e-05	CbGpPWpGaD
